Experimental Cancer Treatments Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AGEN | C | Agenus Inc. | 1.75 | |
REPL | D | Replimune Group, Inc. | -3.35 | |
GNLX | F | Genelux Corporation | 12.28 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Experimental Cancer Treatments stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | F | Loncar Cancer Immunotherapy ETF | 2.04 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.84 | |
ILDR | A | First Trust Innovation Leaders ETF | 0.44 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 0.39 | |
IWC | C | iShares Microcap ETF | 0.19 |
Compare ETFs
Related Industries:
Biotechnology
- Experimental Cancer Treatments
Experimental cancer treatments are treatments that are being tested in clinical trials to determine their safety and effectiveness in treating cancer. These treatments may include new drugs, new combinations of drugs, new surgical procedures, or new ways to use existing treatments.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles